Literature DB >> 11956971

Evaluation of the efficacy of antipsychotic attenuation of phencyclidine-disrupted prepulse inhibition in rats.

J L Wiley1, K L Kennedy.   

Abstract

SUMMARY: Phencyclidine reliably disrupts prepulse inhibition of the acoustic startle response in rats. Previous research has suggested that atypical antipsychotics (e.g., those that do not produce extrapyramidal motor effects) attenuate the disruptive effects of phencyclidine in this model whereas typical antipsychotics do not. Nearly all of this research has used the D2 antagonist haloperidol for comparison. In this study, antipsychotics with more diverse receptor binding profiles were tested for their efficacy in attenuating phencyclidine-induced disruption of prepulse inhibition. Results showed that phencyclidine disrupted prepulse inhibition in all groups of rats. Olanzapine, but not clozapine, attenuated this disruption, but this effect occurred only at a single (5 mg/kg) dose. None of the other antipsychotics nor spermine altered phencyclidine's effects. These results suggest that this model does not reliably differentiate between typical and atypical antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956971     DOI: 10.1007/s007020200043

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  5 in total

1.  Behavioral and molecular evidence for psychotropic effects in L-theanine.

Authors:  Chisato Wakabayashi; Tadahiro Numakawa; Midori Ninomiya; Shuichi Chiba; Hiroshi Kunugi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-23       Impact factor: 4.530

2.  Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.

Authors:  Ming Li; Erik He; Nick Volf
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

3.  Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.

Authors:  B Pouzet; M Paabøl Andersen; S Hogg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

4.  Repeated administration of the novel antipsychotic olanzapine does not modulate NMDA-sensitive glutamate and 5HT2 serotonin receptors in rats.

Authors:  Ottavio Gandolfi; Manuela Voltattorni; Renato Gaggi; Rossella Dall'Olio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-13       Impact factor: 3.000

5.  Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.

Authors:  Rainer Wolf; Katrin Paelchen; Kay Matzke; Henrik Dobrowolny; Bernhard Bogerts; Herbert Schwegler
Journal:  Psychopharmacology (Berl)       Date:  2007-05-31       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.